Copy

Medigus, Ltd. MDGS – News Alert:

We've got more fresh news hitting the wires this morning from MDGS. One of the things we like best about the company is the frequency with which it communicates with its shareholders. 

Today's release pertains to the hiring of an advisory firm to guide Polyrizon, in which Medigus is a stakeholder, toward FDA approval for its nasal gels which are preventative against viruses, including COVID-19 and the flu. 

Tel Aviv, Israel, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Polyrizon Ltd., (37.01%), that it has engaged with a full-service Contract Research Organisation (CRO), to advise the Company in its pursuit of Food and Drug Administration (FDA) submission for its products. (>>View Full PR)
 

Watchlist Updates: 

We typically encourage our readers to keep track of not only the featured items in our daily reports, but our 'Extended Watchlists' as well. They often include hidden opportunities waiting to be unearthed.

Such was the case yesterday with DWAC, which was included in our premarket report before exploding from a daily low of 12.62 up as high as 52.00. That works out to an intraday run of 312%  Our overall observed range has increased already this morning with a premarket high of 93.43, which marks a rise of 640%

We also signaled MGTI on Monday morning, and it has posted a solid intraweek performance thus far. The stock came up from a low of .041  to a high of .064, an increase of 58%
 

Options Recap: 

Last but not least, we went three for three on options ideas in yesterday's report, which provided the following intraday gain opportunities for our readers: 

CSX Weekly $34-36 Calls
$34: 
1.30-1.84 (+42%)
$35: .45-.90 (+100%)
$36: .05-.24 (+380%)
_____

BX Weekly $130-133 Calls
$130: 
2.50-4.83 (+93%)
$131: 1.69-3.67 (+117%)
$132: .93-3.05 (+228%)
$133: .72-2.32 (+222%)
_____

T Weekly $25.50-26.50 Calls 

$25.50: .20-.34 (+70%)
$26: .15-.36 (+140%)
$26.50: .05-.11 (+120%)
_____

Fresh Options Ideas: 
STX Weekly $82.50-85 Calls
AXP Weekly $177.50-182.50 Calls

 

Extended Watchlist:
PHUN, CRTD, GROM, DATS, CZNI, SEGI, TONR, ASTI, NSAV, CIVX, CAGC

View this email in your browser
Twitter Twitter
Facebook Facebook
Website Website
LinkedIn LinkedIn
YouTube YouTube
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Our disclaimer is to be read and fully agreed to before using our site, or joining our email list. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions, however any that may occur will be corrected as needed. BHS and its affiliates are not registered or licensed investment advisers, nor broker dealers. BHS cautions that the investments in companies profiled are commonly considered to be extremely high risk and use of any information provided is at the investor's sole risk.
 

08/23/21 – Owners of this website received $25000USD from a Third-Party for a One Month Market Awareness Campaign on MDGS.

09/24/21- Owners of this website received 30,000 Rule-144 restricted shares of MDGS from a Third-Party for Two Months of Market Awareness Services for MDGS.

Copyright © 2021 BlueHorseshoeStocks.com, All rights reserved.

No longer want to receive our emails? You may unsubscribe from this list at any time.